Problems encountered in the treatment of pregnancy-induced hypertension. A point of view
- PMID: 686045
- DOI: 10.1016/0002-9378(78)90816-5
Problems encountered in the treatment of pregnancy-induced hypertension. A point of view
Abstract
This point of view encountered in the treatment of pregnancy-induced hypertension enumerates the most common problems encountered when treating the disease. These problems include: terminology, etiology and pathogenesis, known facts, failure to identify the patient, loss of life for mother and baby, complications, recognition of early disease, and treatment not uniform or individualized. The severe forms of the disease are preventable and should never occur, but once present they should yield a zero maternal mortality rate and a fetal salvage of greater than 90%. Proper therapy of severe disease is primarily the use of pharmacologic doses of magnesium sulfate given intravenously and the prevention of a cerebral vascular accident in the mother. Induction of labor and removal of the products of conception will cure the disease.
Similar articles
-
Hypertension in pregnancy.J Hypertens Suppl. 1987 Aug;5(3):S57-60. J Hypertens Suppl. 1987. PMID: 2889812 Review.
-
Hypertension in pregnancy.Prim Care. 1983 Jun;10(2):241-52. Prim Care. 1983. PMID: 6554832
-
Preeclampsia and eclampsia.Med J Aust. 1977 Oct 8;2(15):501-4. doi: 10.5694/j.1326-5377.1977.tb117757.x. Med J Aust. 1977. PMID: 600156 No abstract available.
-
Hypertension and pregnancy.Emerg Med Clin North Am. 2012 Nov;30(4):903-17. doi: 10.1016/j.emc.2012.08.006. Emerg Med Clin North Am. 2012. PMID: 23137402
-
The management of hypertension in pregnancy: A review.S Afr Med J. 1980 Jul 19;58(3):103-9. S Afr Med J. 1980. PMID: 6105720 Review.
Cited by
-
Randomized trial to compare acceptability of magnesium sulphate administration for preeclampsia and eclampsia: Springfusor pump versus standard of care.PLoS One. 2024 Jun 12;19(6):e0286361. doi: 10.1371/journal.pone.0286361. eCollection 2024. PLoS One. 2024. PMID: 38865319 Free PMC article. Clinical Trial.
-
Abbreviated 12-Hour Postpartum Magnesium Sulphate Therapy is Equally Effective and Safer Than Standard 24-Hour Therapy in Preeclampsia With Severe Features: Results From A Randomized Controlled Trial.J Family Reprod Health. 2025 Mar;19(1):31-36. doi: 10.18502/jfrh.v19i1.18437. J Family Reprod Health. 2025. PMID: 40352917 Free PMC article.
-
Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia.Cochrane Database Syst Rev. 2023 Oct 10;10(10):CD007388. doi: 10.1002/14651858.CD007388.pub3. Cochrane Database Syst Rev. 2023. PMID: 37815037 Free PMC article.
-
Magnesium sulphate therapy in eclampsia: the Sokoto (ultra short) regimen.BMC Res Notes. 2009 Aug 19;2:165. doi: 10.1186/1756-0500-2-165. BMC Res Notes. 2009. PMID: 19691837 Free PMC article.
-
Magnesium sulphate versus diazepam for eclampsia.Cochrane Database Syst Rev. 2010 Dec 8;2010(12):CD000127. doi: 10.1002/14651858.CD000127.pub2. Cochrane Database Syst Rev. 2010. PMID: 21154341 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources